Minimally Invasive Surgery Market to Expand at 10.50% CAGR

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Minimally Invasive Surgery Market to Expand at 10.50% CAGR by 2019; Driven by Technological Advancements: Transparency Market Research

Albany, NY, Jan. 21, 2016 (GLOBE NEWSWIRE) -- According to a recent market research report released by Transparency Market Research, the global minimally invasive surgery market, according to a report published by Transparency Market Research. The report, titled “ Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 ”, states that exhibiting a robust CAGR of 10.50% from 2013 to 2019, the minimally invasive surgery market is anticipated to expand from a value of US$25 bn in 2012 to US$50.6 bn in 2019.

Key reasons for the double-digit growth of this market include the rise in incidences of various diseases such as kidney stone, cancer, cardiovascular diseases (CVDs) and arthritis globally that has greatly expanded the target patient population seeking MIS procedures. Similarly, rise in disposable incomes in various nations such as India, China, Brazil, Mexico and others will also augment the growth of this market since it will increase the affordability for these medical services for the patients.

Browse Research Study on Minimally Invasive Surgery Market: http://www.transparencymarketresearch.com/min...arket.html

Recent Trends in the Market:

The minimally invasive surgery market is divided into three categories based on product type: surgical devices, endoscopy devices, and monitoring and visualization devices. In 2012, the surgical devices segment – comprising medical robotic systems, electrosurgical devices, and ablation devices – held the largest share of the minimally invasive surgery market and this segment is also anticipated to register the highest growth rate during the forecast period.

On the basis of type of surgery, the market for minimally invasive surgeries is categorized into cosmetic, vascular, gynecological, cardiac, urological, orthopedic, breast surgery, thoracic, bariatric, and gastrointestinal. In terms of revenue, the cardiac surgery segment held the largest share of the minimally invasive surgery market in 2012 owing to rising prevalence of cardiovascular diseases and ailments across the globe. Cosmetic surgery, on the other hand, is anticipated to develop at the highest growth rate from 2013 to 2019 thanks to rising disposable incomes and increasing demand for cosmetic surgeries

Based on geography, the global minimally invasive surgery market is segmented into Asia-Pacific, North America, Europe, and Rest of the World. Among these, North America dominates the overall market thanks to large patient population, presence of leading manufacturers, and a well-defined reimbursement policy.

Avail a Sample Copy of Research Report: http://www.transparencymarketresearch.com/sam...ep_id=1356  

Asia Pacific, on the other hand, is estimated to emerge as the fastest growing regional segment of the minimally invasive surgery market, demonstrating a 13.30% CAGR from 2013 to 2019. This regional market is fueled by rising geriatric population, growth of medical tourism in countries such as Thailand, Malaysia, and India, increasing medical and healthcare expenditure, growing interest in the region by medical device manufacturers, and rise in disposable incomes. 

The leading companies engaged in the global minimally invasive surgery market include NuVasive, Inc., Biomet, Inc., Surgical Innovations Group plc. Given Imaging Ltd., Teleflex, Inc., Philips Healthcare, Medtronic, Inc., Stryker Corporation, Varian Medical Systems, Inc., Siemens Healthcare, Abbott Laboratories, Inc., ArthroCare Corporation, Intuitive Surgical, Inc., DePuy Synthes, Inc., and GE Healthcare. These players are profiled in the minimally invasive surgery market report based on attributes such as product portfolio, business strategies, company overview, recent developments, and financial outlook.

Related Report:

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading